Literature DB >> 19460555

Use of venovenous extracorporeal membrane oxygenation as a bridge to urgent lung transplantation in a case of acute respiratory failure.

L Santambrogio1, M Nosotti, A Palleschi, D Tosi, P Mendogni, A Lissoni, F Blasi, L Rosso.   

Abstract

Several transplant centers consider pretransplant extracorporeal membrane oxygenation (ECMO) as a contraindication for lung transplantation because of the poor outcomes. However, some technical improvements have changed the scenario; there is increasing evidence of ECMO efficacy as a bridge to lung transplantation. This report describes the successful use of venovenous ECMO as a bridge to an urgent bilateral lung transplantation and as treatment for primary graft dysfunction in a case of hyperacute pulmonary fibrosis in a 58-year-old man. Our experience demonstrated that ECMO, using Quadrox, supported respiratory functions for 28 days without any detrimental effects, serving as a successfully bridge to urgent lung transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19460555     DOI: 10.1016/j.transproceed.2009.02.065

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation.

Authors:  Sonja Darrell Bartolome; Fernando Torres
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

2.  Approach to acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Hammad Bhatti; Ankur Girdhar; Faisal Usman; James Cury; Abubakr Bajwa
Journal:  Ann Thorac Med       Date:  2013-04       Impact factor: 2.219

Review 3.  Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.

Authors:  Spyros A Papiris; Effrosyni D Manali; Likurgos Kolilekas; Konstantinos Kagouridis; Christina Triantafillidou; Iraklis Tsangaris; Charis Roussos
Journal:  Crit Care       Date:  2010-12-22       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.